Related Experiment Video
Updated: Jun 20, 2026

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
[First experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary
Terapevticheskii Arkhiv
|August 28, 2009
Abstract:
Primary skin large B-cell lymphosarcomas (PLBCL) present with skin lesions, other organs and systems are not involved. As CHOP courses are not high effective in PLBCL, we were the first to treat a patient with modified block therapy NHL BFM-90. A complete remission was achieved after the first course of polychemotherapy and was consolidated by two courses of treatment. Further follow-up is needed.